NxEdge AI, Inc. (NASDAQ: NXU (NASDAQ:NXU)) is a technology company specializing in the development and commercialization of non‐invasive, AI-enabled biosensing solutions. Formerly known as Know Labs, the company has pioneered its Bio-RFID platform, which leverages radio frequency and electromagnetic wave engineering to measure key physiological metrics through skin contact. Targeting both consumer and industrial applications, NxEdge AI is positioning its sensor technology as a versatile tool for health monitoring, wellness tracking, and precision agriculture.
The company’s Bio-RFID sensor modules are designed to be embedded into a variety of form factors, including wristbands, fitness devices, and handheld readers, providing real-time measurements of hydration levels, body composition, and other biometric indicators. In addition to human health and fitness markets, NxEdge AI is exploring opportunities in veterinary care and livestock management, where continuous, non-invasive monitoring can enhance animal welfare and farm productivity. The company pursues strategic partnerships with electronics manufacturers and research institutions to integrate its sensors into new product lines.
Founded as Know Labs in 1991, the organization underwent a strategic shift in the mid-2010s to focus on its electromagnetic biosensing technologies. In early 2023, the company rebranded as NxEdge AI to reflect its broader emphasis on edge computing, artificial intelligence and machine learning. Headquartered in Bothell, Washington, with research and development operations in Vancouver, Canada, NxEdge AI has presented prototypes at international trade shows and is establishing distribution channels across North America, Europe, and Asia through collaboration agreements and joint development projects.
Under the leadership of President and Chief Executive Officer Andrew Rickman, the inventor of the Bio-RFID platform, NxEdge AI has built a management team with deep expertise in electronics, software development and life sciences. Chief Financial Officer Mark Brunelli oversees corporate finance and investor relations, while Chief Technology Officer Dr. Bryan McPherson guides research initiatives and patent strategy. With a portfolio of issued and pending patents, the company is advancing its sensor technology toward commercial launch and regulatory clearances in key markets.
